are compounded semaglutides still available Semaglutide Safety: What You Should Know Compounded Semaglutide for Weight Loss

Description

The science of slowed gastrointestinal motility GLP-1 receptor agonists act on the gutbrain axis and are known to slow gastric emptying and overall gastrointestinal transit , contributing to early satiety and appetite suppression. As intestinal transit slows, the colon has more time to absorb water from stool , leading to hard, dry stools that are difficult to pass . Constipation is a common, dose-related adverse effect listed in FDA prescribing information for both Wegovy (semaglutide) and Zepbound (tirzepatide) and is most frequently reported during dose escalation , with improvement over time., Step-by-Step MD Protocol for Relief 1

Foods rich in omega-3 fatty acids can significantly impact GLP-1 levels

Expert Opin Drug Saf 11(4):615634

Side effects vary by person

This success has led to speculation about broader impacts on the medtech industry, given its principal role in the treatment and management of obesity and its comorbidities